The Biology of Prostate Cancer Skeletal Metastases
The Biology of Prostate Cancer Skeletal Metastases
批准号:
7630981
负责人:
Evan T Keller
金额:
$151.18万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-05 至 2014-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The common occurrence and serious outcome of prostate cancer (PCa) skeletal metastases has risen to the forefront of public concern and subsequently the NCI. In the first three years of this program award, we have addressed this important issue, resulting in over 50-grant-related publications. In the current competitive renewal, we continue to attack this problem by combining leading expertise in PCa research and bone metabolism. The ultimate goal is to define the cellular and molecular mechanisms that surround PCa skeletal metastases so as to set the groundwork for translation into clinical applications. The central theme of this Program is that there is crosstalk between PCa cells and the bone microenvironment that foster the development and progression of PCa metastasis. This crosstalk promotes the ability of PCa cells to migrate, attach, and manipulate the cells in bone thus enhancing the tumor's capacity to alter the bone microenvironment to render it conducive to tumor growth. To expand on this theme the Program encompasses closely interrelated hypotheses of four scientific projects supported by three cores. Project 1 explores the novel concept that the similar to an endocrine organ, the primary PCa modulates the distant bone marrow, in part through production of CCLZ, to make it conducive for receiving metastatic PCa cells; Project 2 examines the exciting idea that PCa cells co-opt the hematopoietic stem cell (HSC) niche in the bone marrow; Project 3 explores the unexpected role of the Wnt inhibitor Dickopff as a molecular switch that promotes the osteoblastic phenotype of PCa; and, Project 4 investigates the novel hypothesis that PCa, through PTHrP, modulates osteoblasts and HSCs leading to angiogenesis in the bone microenvironment that promotes PCa progression. These projects will be supported by three integral cores: Core A (Administration) that will coordinate reporting, evaluation, and committee activities, facilitate interactions among the projects and provide biostatistical support; Core B (Animal) provides mouse models and imaging and assistance with their use and Core C (Bone) provides expertise with bone histology processing and interpretation. This combination of investigators, projects and cores result in a highly synergistic Program that will continue to provide cutting-edge research on PCa bone metastases.
RELEVANCE (See instructions): Prostate cancer (PCa) is the most common cancer of American men and the second leading cause of cancer-related death. When men die from PCa, it is almost always accompanied by the painful and debilitating spread of cancer to the skeleton. Our Program is directed to understand how the cancer spreads to and thrives in the skeleton so that we can develop method to prevent or treat the spread of PCa to the bone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Sensitivity and Resistance to the Kinase Inhibitor Cabozantinib
-
批准号:8788150
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2014
-
负责人:Evan T Keller
-
依托单位:
Microfluidic PCR System for Single Cell Transcriptional Analysis
-
批准号:8446702
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2013
-
负责人:Evan T Keller
-
依托单位:
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
-
批准号:8333998
-
项目类别:
-
资助金额:$61.25万
-
财政年份:2011
-
负责人:Evan T Keller
-
依托单位:
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
-
批准号:8713957
-
项目类别:
-
资助金额:$49.55万
-
财政年份:2011
-
负责人:Evan T Keller
-
依托单位:
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
-
批准号:8536247
-
项目类别:
-
资助金额:$48.72万
-
财政年份:2011
-
负责人:Evan T Keller
-
依托单位:
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
-
批准号:8213014
-
项目类别:
-
资助金额:$54.1万
-
财政年份:2011
-
负责人:Evan T Keller
-
依托单位:
Aging Rodent Core
-
批准号:8122845
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2010
-
负责人:Evan T Keller
-
依托单位:
In vivo non-invasive 3D quantitative IVIS Spectrum molecular imaging system
-
批准号:7791805
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2010
-
负责人:Evan T Keller
-
依托单位:
CORE--AGING TRANSGENIC RODENT/PATHOLOGY
-
批准号:6948014
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2005
-
负责人:Evan T Keller
-
依托单位:
Project 3: The osteocyte-driven GDF15:GFRAL axis promotes prostate cancer bone metastasis
-
批准号:10427247
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
Prostate Cancer Metastasis Suppressor: Role of RKIP
-
批准号:6872148
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
Administrative Core
-
批准号:8854464
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
The Biology of Prostate Cancer Skeletal Metastases
-
批准号:8854463
-
项目类别:
-
资助金额:$151.94万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
Core B - Animal Core
-
批准号:10629277
-
项目类别:
-
资助金额:$35.24万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
Animal Core
-
批准号:7659017
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
The Biology of Prostate Cancer Skeletal Metastases
-
批准号:7282340
-
项目类别:
-
资助金额:$143.44万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
Administrative Core
-
批准号:9163104
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
Core A - Administrative Core
-
批准号:10427249
-
项目类别:
-
资助金额:$22.07万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
Prostate Cancer Metastasis Suppressor: Role of RKIP
-
批准号:6776821
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
The Biology of Prostate Cancer Skeletal Metastases
-
批准号:7885548
-
项目类别:
-
资助金额:$156.83万
-
财政年份:2004
-
负责人:Evan T Keller
-
依托单位:
海外基金